The use of a web-based decision aid with value clarification exercises will improve patients' knowledge and will give patients realistic expectations of risks and benefits. Addition of the G8 (frailty instrument) and the Timed Up and Go-test as…
ID
Bron
Verkorte titel
Aandoening
Shared decision making, decision aid, prostate cancer, CRPC
Ondersteuning
Postbus 90151
5000 LC Tilburg
Delfland 17
1062 EA Amsterdam
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
- Objective knowledge<br>
- Informed choice
Achtergrond van het onderzoek
We will conduct a stepped wedge randomized controlled trial. Each hospital will start as control (standard care) and will switch randomly to the implementation of the decision aid at consecutive time points. The effectiveness of the decision aid will be assessed with questionnaires before and after implementation. Participants are asked to complete a questionnaire at four different points in time: shortly after being diagnosed (T0 = baseline), at the point of decision making (T1), and at follow up 3 and 6 months.
Doel van het onderzoek
The use of a web-based decision aid with value clarification exercises will improve patients' knowledge and will give patients realistic expectations of risks and benefits. Addition of the G8 (frailty instrument) and the Timed Up and Go-test as supportive screening tools will help clinicians to recognize frail patients who might require adapted treatment.
Onderzoeksopzet
The effectiveness of the decision aid will be assessed with questionnaires before and after implementation. Participants are asked to complete a questionnaire at four different point in time: shortly after being diagnosed (T0 = baseline), at the point of decision making (T1), and at follow up 3 and 6 months.
Onderzoeksproduct en/of interventie
Decision aid with value clarification exercise
Publiek
Isabel de Angst
Postbus 90151
Tilburg 5000 LC
The Netherlands
i.deangst@etz.nl
Wetenschappelijk
Isabel de Angst
Postbus 90151
Tilburg 5000 LC
The Netherlands
i.deangst@etz.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Men that are newly diagnosed with CRPC. CRPC is defined as any cancer progression under maximal hormonal treatment with anti-androgens and/or LHRH agonist or antagonist (when three consecutive rises of PSA are observed at castrate serum levels of testosterone (< 50 ng/dL or <1.7 nmol/L) and/or progression of osseous lesions is shown))
- Patients are eligible for at least two treatment options
- Patients have to be able to make use of a computer with internet-access in order to make use of the web-based decision aid
- Patients have to be able to complete a Dutch questionnaire
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- In the case of a second opinion the patient will not be included if the first opinion was obtained in one of the other involved hospitals and vice versa
- Patients who do not have sufficient knowledge of the Dutch language
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL6223 |
| NTR-old | NTR6379 |
| Ander register | METZ Brabant/16.280 : NW2016-55 |